Systemic pharmacologic tx6 recommended if bladder training unsuccessful [SR/H]. Base choice of agent on tolerability, ADR profile,7 ease of use, and cost [SR/H]:

By rray, 24 December, 2014
Exclude Patient Type Detail Header
No
Detail Type
Text
Detail Text
Antimuscarinic agents8 (oxybutynin, tolterodine, darifenacin, solifenacin, fesoterodine, and trospium) increased continence rates and improved UI. Consider ADR9 risk vs severity/bothersomeness of UI
β3-adrenoceptor agonist8 (mirabegron) achieved continence and improved UI better than placebo. Consider ADR10 risk vs severity/bothersomeness of UI
Patient Type Detail Header (Long)
Systemic pharmacologic tx<sup>6</sup> recommended if bladder training unsuccessful [SR/H]. Base choice of agent on tolerability, ADR profile,<sup>7</sup> ease of use, and cost [SR/H]: